Hicks, K. A., Mahaffey, K. W., Mehran, R., Nissen, S. E., Wiviott, S. D., Dunn, B., . . . Temple, R. J. (2018). 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. Circulation (New York, N.Y.), 137(9), 961. https://doi.org/10.1161/CIRCULATIONAHA.117.033502
Chicago Style (17th ed.) CitationHicks, Karen A., et al. "2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials." Circulation (New York, N.Y.) 137, no. 9 (2018): 961. https://doi.org/10.1161/CIRCULATIONAHA.117.033502.
MLA (9th ed.) CitationHicks, Karen A., et al. "2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials." Circulation (New York, N.Y.), vol. 137, no. 9, 2018, p. 961, https://doi.org/10.1161/CIRCULATIONAHA.117.033502.
Warning: These citations may not always be 100% accurate.